The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare, low-grade multisystem neoplastic disease. Most LAM patients are at a high risk of losing lung function at an accelerated rate and developing progressive dyspnea. Recently, several studies have reported their experience with pharmacological treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Luo, Mengqi, Xiang, Bo, Chen, Siyuan, Ji, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023761/
https://www.ncbi.nlm.nih.gov/pubmed/32059669
http://dx.doi.org/10.1186/s12931-020-1316-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023761/
https://www.ncbi.nlm.nih.gov/pubmed/32059669
http://dx.doi.org/10.1186/s12931-020-1316-3

Ejemplares similares